These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 18786088

  • 1. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S.
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [Abstract] [Full Text] [Related]

  • 2. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [Abstract] [Full Text] [Related]

  • 3. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 4. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H, Ozerkan F, Zoghi M, Nalbantgil S, Yildiz A, Akilli A, Akin M, Nazli C, Ergene O.
    Int J Clin Pract; 2008 Feb 01; 62(2):228-33. PubMed ID: 17949428
    [Abstract] [Full Text] [Related]

  • 5. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct 01; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
    Triposkiadis F, Dalampiras P, Kelepeshis G, Skoularigis J, Sitafidis G.
    Int J Clin Pharmacol Ther; 2008 Mar 01; 46(3):136-9. PubMed ID: 18397684
    [Abstract] [Full Text] [Related]

  • 7. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.
    Eur J Heart Fail; 2010 Apr 01; 12(4):404-10. PubMed ID: 20335355
    [Abstract] [Full Text] [Related]

  • 8. The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.
    Lehtonen L, Sundberg S.
    Eur J Clin Pharmacol; 2002 Oct 01; 58(7):449-52. PubMed ID: 12389066
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A, Quatrini I, Vecchiato L, Scali C, De Paola V, Iovine F, Martini G, Nuti R.
    Minerva Cardioangiol; 2005 Aug 01; 53(4):321-8. PubMed ID: 16177676
    [Abstract] [Full Text] [Related]

  • 10. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 01; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 11. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR.
    Int J Cardiol; 2001 Dec 01; 81(2-3):141-9. PubMed ID: 11744130
    [Abstract] [Full Text] [Related]

  • 12. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    Duygu H, Ozerkan F, Nalbantgil S, Zoghi M, Akilli A, Akin M, Nazli C, Ergene O.
    Int J Cardiol; 2008 Jan 11; 123(2):201-3. PubMed ID: 17316845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 16. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A, Andersson B, Edner M, Nylander E, Persson H, Dahlström U.
    Eur J Heart Fail; 2004 Jun 02; 6(4):453-61. PubMed ID: 15182771
    [Abstract] [Full Text] [Related]

  • 17. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Cardiovasc Ther; 2013 Apr 02; 31(2):108-14. PubMed ID: 23490237
    [Abstract] [Full Text] [Related]

  • 18. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M, Cavuşoğlu Y, Demirüstü C, Birdane A, Ünalır A, Görenek B, Göktekin Ö, Ata N.
    Turk Kardiyol Dern Ars; 2010 Jul 02; 38(5):334-40. PubMed ID: 21200103
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A.
    Crit Care Med; 2007 May 02; 35(5):1376-82. PubMed ID: 17414729
    [Abstract] [Full Text] [Related]

  • 20. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.